Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa
| dc.contributor.author | Chadwick, David | |
| dc.contributor.author | Phillips, Richard Odame | |
| dc.contributor.author | Stanley, Alastair | |
| dc.contributor.author | Sarfo, Fred Stephen | |
| dc.contributor.author | Appiah, Lambert | |
| dc.contributor.author | et. al | |
| dc.date.accessioned | 2020-01-10T12:42:21Z | |
| dc.date.accessioned | 2023-04-19T01:43:17Z | |
| dc.date.available | 2020-01-10T12:42:21Z | |
| dc.date.available | 2023-04-19T01:43:17Z | |
| dc.date.issued | 2013 | |
| dc.description | An article published by Lippincott Williams & Wilkins and available at DOI:10.1097/QAD.0b013e3283589879 | en_US |
| dc.description.abstract | This study evaluated the outcome of first-line antiretroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAgR HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBVand HBsAgR patients. Occult HBV/HIV coinfection appears not to impact adversely on response to antiretroviral therapy in Ghana. | en_US |
| dc.description.sponsorship | KNUST | en_US |
| dc.identifier.citation | Lippincott Williams & Wilkins Vol 27 No 1 | en_US |
| dc.identifier.uri | https://ir.knust.edu.gh/handle/123456789/11893 | |
| dc.language.iso | en | en_US |
| dc.publisher | Lippincott Williams & Wilkins | en_US |
| dc.title | Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa.pdf
- Size:
- 190.23 KB
- Format:
- Adobe Portable Document Format
- Description: